Results 11 to 20 of about 163,269 (195)

Severe megaloblastic anemia in a patient with advanced lung adenocarcinoma during treatment with erlotinib: a case report and literature review. [PDF]

BMC Pulm Med
Background Erlotinib is a first-generation, tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR-TKI) used for the treatment patients with NSCLC.
Yan X, Kong J, Wang J, Wang C, Shen H.
europepmc   +3 more sources

Massive Splenomegaly: A Rare Presentation of Megaloblastic Anemia. [PDF]

Int J Hematol Oncol Stem Cell Res, 2021
Megaloblastic anemia is a common disorder with various manifestations. Of the many causes, cobalamin or folate deficiency can eventuate into megaloblastic anemia.
Gholipur-Shahraki T, Sadeghi A, Oghab P, Farrokhi P, Moghaddas A.   +4 more
europepmc   +2 more sources

Megaloblastic anemia associated with small bowel resection in an adult patient [PDF]

Nigerian Journal of Medicine, 2021
Megaloblastic anemia is characterized by macro-ovalocytosis, cytopenias, and nucleocytoplasmic maturation asynchrony of marrow erythroblast. The development of megaloblastic anemia is usually insidious in onset, and symptoms are present only in severely ...
Ajayi Adeleke Ibijola, Abiodun Idowu Okunlola   +1 more
doaj   +2 more sources

MEGALOBLASTIC ANEMIA IN CHILDREN: CASE SERIES FROM A SINGLE INSTITUTION AND LITERATURE REVIEW [PDF]

Romanian Journal of Pediatrics, 2018
Folic acid and cobalamin are B-group vitamins that play an essential role in many cellular processes. Deficiency in one or both of these vitamins causes megaloblastic anemia, a very rare anemia in children, which is characterized by the presence of ...
Andreea Oltean, Mihaela Ioana Chincesan, Maria Despina Baghiu, Eniko Molnar, Cristina Oana Marginean   +4 more
doaj   +3 more sources

Thiamine-responsive megaloblastic anemia syndrome with novel compound heterozygous SLC19A2 mutations and thrombotic events: a case report. [PDF]

J Med Case Rep
Background Thiamine-responsive megaloblastic anemia syndrome represents a rare autosomal recessive condition originating from mutations in the SLC19A2 gene.
Jiménez FX, Rojas C, Fernandez HA, Ruiz-Urbáez R, Reyes-Silva C, Guamán J, Carrión M, Naranjo-Saltos F.   +7 more
europepmc   +2 more sources

Novel Homozygous Variant in the SLC19A2 Gene Causing Thiamine Responsive Megaloblastic Anemia Syndrome: A Disease to Be Considered in Diabetes Clinics

Endocrinology Research and Practice
Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare syndrome with an autosomal recessive manner that develops due to a mutation in the SLC19A2gene.
Burcak Cavnar Helvaci, Hanife Saat, Sema Hepsen, Özant Helvaci, Erman Cakal   +4 more
doaj   +4 more sources

Megaloblastic anemia-related iron overload and erythroid regulators: a case report. [PDF]

J Med Case Rep, 2021
Background In ineffective erythropoiesis, hepcidin synthesis is suppressed by erythroid regulators, namely erythroferrone and growth differentiation factor-15.
Vallet N, Delaye JB, Ropert M, Foucault A, Ravalet N, Deriaz S, Chalopin T, Blasco H, Maillot F, Hérault O, Gyan E.   +10 more
europepmc   +2 more sources

Megaloblastic Anemia in Bardet-Biedl Syndrome: A Rare Case Report. [PDF]

Clin Med Insights Case Rep, 2023
Background: Bardet-Biedl syndrome (BBS) also known as Laurence-Moon-Bardet-Biedl syndrome one of the rarely reported genetic disorder characterized by an intellectual disability, limb, kidney abnormalities, obesity, and Rod-cone dystrophy.
Hassan S, Khan QA, Saravanan P, Iram S, Rohail S, Belay NF, Afzal M, Hadi FA, Pande H.   +8 more
europepmc   +2 more sources

Rogers Syndrome, an Uncommon Cause of Megaloblastic Anemia: A Case Series. [PDF]

Adv Biomed Res
The present case series describes two male children of 5 months and 11 months old, having diabetes mellitus and megaloblastic anemia, but with no syndromic symptoms or organ involvement.
Roshan R, Mehboob M, Latif R, Bhat JR, Rathod SG.   +4 more
europepmc   +2 more sources

Megaloblastic anemia - A clinical spectrum and a hematological profile: The day-to-day public health problem

Medical Journal of Dr. D.Y. Patil University, 2016
Aims and Objectives: To know the various parameters and diagnostic approach of megaloblastic anemia. To know the age incidence and sex ratio. Materials and Methods: A hospital-based retrospective and prospective study was done for a period of 1-year ...
S Srikanth
doaj   +2 more sources